Wugen

Raised $115M, announced 4 September 2025.

Total raised: $115M

Country United StatesSector Health

Round

$115MRound, 4 September 2025

Funds the pivotal T-RRex trial and manufacturing scale-up ahead of a 2027 BLA filing.

Amount: $115M
Announced: 4 September 2025
Lead: Fidelity Management & Research
Other investors: RiverVest Venture Partners, Abingworth, ICG, Lightchain Capital, LYZZ Capital, Tybourne Capital Management, Aisling Capital Management
Use of funds: Funds the pivotal T-RRex trial and manufacturing scale-up ahead of a 2027 BLA filing.
Checked: Amount and date checked against the press source
Source: Wugen raises $115M Equity financing (date approx) pulse2.com

Company

Clinical-stage biotech developing donor-derived gene-edited CAR-T therapy for T-cell leukemia and lymphoma

Based in: St. Louis, United States
Sector: Health
Website: wugen.com ↗

Questions

How much has Wugen raised?

Wugen raised $115M, announced on 4 September 2025.

Who invested in Wugen?

Fidelity Management & Research led. Investors include Fidelity Management & Research, RiverVest Venture Partners, Abingworth, ICG, Lightchain Capital and LYZZ Capital.